רנקסה 1000 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

RANOLAZINE 1000 MG

MAH:

NEOPHARM LTD

ATC_code:

C01EB18

pharmaceutical_form:

TABLETS EXTENDED RELEASE

administration_route:

PER OS

manufactured_by:

CV THERAPEUTICS INC, USA

therapeutic_group:

RANOLAZINE

therapeutic_indication:

Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

authorization_date:

2010-10-01